hotspot -WSS

hotspot

author：focus 2025-10-01 18:23:50 - browse：9

Two boxes of Humira and a Humira pen on the side — first opinion coverage from STAT — David J. Phillip/AP

It’s been one year since the launch of the first adalimumab biosimilar for Humira in the United States, which was followed by eight additional adalimumab biosimilar launches. These nine FDA-approved products offer lower-cost alternatives to the world’s bestselling drug, Humira, used to treat rheumatoid arthritis, Crohn’s disease, and other autoimmune disorders. This made 2023 a watershed year for millions of U.S. patients paying too much for their necessary medications.

But so far, that vision hasn’t come to fruition, because policymakers haven’t taken the action necessary to be sure these lower-cost products are accessible for patients. If they fail to act, the U.S. health care system could lose up to $133 billion in savings and leave patients without access to the medicines they need.

Biosimilars are safe and effective treatments referencing biologic drugs. They are market disruptors, forcing lower prices for biologic medicines. The cost savings from reference biologic products begins almost immediately when biosimilars enter the market and continues over time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： With heat waves through August, officials warn of health risks

focus

WSS

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

It was time to plan for my old age. If only I could stop crying

Flu vaccine reformulation won't be easy, manufacturers warn

Judge in Trump's classified documents case questions use of out

CVS is on a mission to consolidate health care. Will it work?

The inclusion problem at the heart of rehabilitation research

hotspot

hotspot

leisure time

Medical leaders decry Supreme Court decision on affirmative action

Kansas bar where gunfire wounded 9 last month closes permanently

Affirmative action in medical school literally saved lives

Pennsylvania man bitten on the head by bear during attack in his garage

Affirmative action in medical school literally saved lives

High breast density mammograms need follow

Medical leaders decry Supreme Court decision on affirmative action

Medicare bonuses could stop drug shortages under Senate plan

As demand for Covid shots wanes, Moderna seeks its next success

Medicare drug price lawsuits could be good politics for Biden

leisure time

What causes osteoarthritis? Researchers study link to brain protein

Sweden knocks USA out of World Cup in penalty kicks

Prior authorization reform is both possible and imperative

Sage considers ways to reduce costs following FDA rejection

How CRISPR works, explained in two minutes

Dog Aging Project founders on what lies ahead after losing funding

knowledge

hotspot

focus

hotspot